Recombinant ITGB2 (Erlizumab Biosimilar) antibody
This Humanized Chimeric antibody specifically detects ITGB2 (Erlizumab Biosimilar) . It exhibits reactivity toward Human.
Catalog No. ABIN7597671
$401.14
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant ITGB2 (Erlizumab Biosimilar) antibody (ABIN7597671)
Target
ITGB2 (Erlizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Erlizumab Biosimilar Antibody
-
Specificity
- Complement receptor C3 subunit beta, Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta, Integrin beta-2, MFI7, CD18, ITGB2
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- ITGB2 (Erlizumab Biosimilar)
-
Alternative Name
- Erlizumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Complement receptor C3 subunit beta, Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta, Integrin beta-2, MFI7, CD18, ITGB2
-
UniProt
- P05107
-
CAS-No
- 211323-03-4
Target
-
You are here:
